MX9206216A - Preparacion de antigenos y de vacunas del virus de la enfermedad misteriosa, antigenos y vacunas obtenidos para la prevencion de dicha enfermedad - Google Patents

Preparacion de antigenos y de vacunas del virus de la enfermedad misteriosa, antigenos y vacunas obtenidos para la prevencion de dicha enfermedad

Info

Publication number
MX9206216A
MX9206216A MX9206216A MX9206216A MX9206216A MX 9206216 A MX9206216 A MX 9206216A MX 9206216 A MX9206216 A MX 9206216A MX 9206216 A MX9206216 A MX 9206216A MX 9206216 A MX9206216 A MX 9206216A
Authority
MX
Mexico
Prior art keywords
antigens
disease
vaccines
virus
mysterious
Prior art date
Application number
MX9206216A
Other languages
English (en)
Inventor
Andre Brun
Alain Vaganay
Marie-Claude Tardy
Joris Vande-Putte
Original Assignee
Rhone Merieux
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Merieux filed Critical Rhone Merieux
Publication of MX9206216A publication Critical patent/MX9206216A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

El procedimiento de aislamiento del virus de la enfermedad misteriosa implica la extracción de órganos de los cerdos enfermos infectados, la trituración de los órganos extraídos, y hacer pasar el sobrenadante de la trituración, sobre células sensibles, heterólogas u homólogas, y posteriormente, recoger el sobrenadante. Para la producción industrial del virus de la enfermedad misteriosa, se cultiva el virus sobre células sensibles, hetrólogas u homólogas.
MX9206216A 1991-10-29 1992-10-28 Preparacion de antigenos y de vacunas del virus de la enfermedad misteriosa, antigenos y vacunas obtenidos para la prevencion de dicha enfermedad MX9206216A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9113338A FR2682966B1 (fr) 1991-10-29 1991-10-29 Preparation d'antigenes et de vaccins du virus de la mystery disease, antigenes et vaccins obtenus pour la prevention de cette maladie.

Publications (1)

Publication Number Publication Date
MX9206216A true MX9206216A (es) 1993-12-01

Family

ID=9418419

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9206216A MX9206216A (es) 1991-10-29 1992-10-28 Preparacion de antigenos y de vacunas del virus de la enfermedad misteriosa, antigenos y vacunas obtenidos para la prevencion de dicha enfermedad

Country Status (4)

Country Link
EP (1) EP0541418A1 (es)
CA (1) CA2081638A1 (es)
FR (1) FR2682966B1 (es)
MX (1) MX9206216A (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2686097B1 (fr) * 1992-01-14 1994-12-30 Rhone Merieux Preparation d'antigenes et de vaccins de virus de la mystery disease, antigenes et vaccins obtenus pour la prevention de cette maladie.
KR100374295B1 (ko) * 1993-02-08 2003-12-24 바이엘 코포레이션 돼지생식및호흡증후군바이러스의생육방법과백신에서그의용도
GB2289279B (en) * 1994-05-13 1998-09-16 Iberica Cyanamid Diagnostic kits and vaccines containing recombinant PRRSV proteins

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5052224A (es) * 1973-09-10 1975-05-09
DD145705A1 (de) * 1979-08-31 1981-01-07 Peter Solisch Herstellungsverfahren von organspezifischen retrovirusimmunpraeparaten fuer prophylaxe,therapie und diagnostik
JPS5879929A (ja) * 1981-11-05 1983-05-13 Biseibutsu Kagaku Kenkyusho:Kk 日本脳炎・豚パルポ混合ワクチン
JPS5939831A (ja) * 1982-08-27 1984-03-05 Biseibutsu Kagaku Kenkyusho:Kk 豚用インフルエンザウイルス不活化ワクチン
IL70704A0 (en) * 1983-01-19 1984-04-30 Amgen Methods and materials for development of parvovirus vaccines
JPS62198626A (ja) * 1986-02-26 1987-09-02 Biseibutsu Kagaku Kenkyusho:Kk 血球凝集性脳脊髄炎ウイルス感染症予防ワクチン
JP2538367B2 (ja) * 1988-06-24 1996-09-25 ブリティッシュ・テクノロジー・グループ・リミテッド Ｆｏｗｌｐｏｘウィルスの非必須領域
EP0351908B1 (en) * 1988-07-18 1994-10-05 Duphar International Research B.V Live newcastle disease virus vacccines

Also Published As

Publication number Publication date
FR2682966B1 (fr) 1994-12-02
FR2682966A1 (fr) 1993-04-30
EP0541418A1 (fr) 1993-05-12
CA2081638A1 (en) 1993-04-30

Similar Documents

Publication Publication Date Title
Marchette et al. Studies on the pathogenesis of dengue infection in monkeys. III. Sequential distribution of virus in primary and heterologous infections
ES2142874T3 (es) Preparacion de antigenos y de vacunas de virus de la enfermedad misteriosa, antigenos y vacunas obtenidas para la prevencion de esta enfermedad.
HUP0203817A2 (hu) Polioxietilén-alkil-étert vagy -észtert és legalább egy nemionos felületaktív anyagot tartalmazó adjuváns
ES2176232T3 (es) Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter.
HUP0203335A1 (hu) Vakcina
SE9003198D0 (sv) Fish vaccine comprising a virulent, invasive bacterium
ATE297218T1 (de) Impfstoff gegen mehrere fiv-subtypen
DE3889138D1 (de) Influenza-Impfstoff.
ES498752A0 (es) Un procedimiento para preparar una vacuna de virus vivos de la peritonitis infecciosa de los felinos
MX9206216A (es) Preparacion de antigenos y de vacunas del virus de la enfermedad misteriosa, antigenos y vacunas obtenidos para la prevencion de dicha enfermedad
AU2003288510A8 (en) Immunizing fish against viral infection
ES2088431T3 (es) Preparacion biologica y su utilizacion.
ATE354370T1 (de) Inaktivierte immunogene bakterielle ganzzell- zusammensetzungen
DE3854857D1 (de) Verhütung und behandlung einer retrovirenkrankheit
ES2066206T3 (es) Utilizacion de adenilciclasa como vacunas contra bordetella.
DE69102649D1 (de) Hrsv-vakzine.
Cheirmaraj et al. Immunoprophylaxis against filarial parasite, Brugia malayi: potential of excretory-secretory antigens in inducing immunity
Santamarina et al. Requirements for the induction of cross-reactive anti-Trichinella IgE antibodies in mice
Collier et al. The spontaneous polyarthritis of rats and the syndrome induced by inoculation of human material in these animals
Epstein The Vaccine Control of Virus-Induced Cancers
RO82518B1 (ro) Procedeu de obtinere a vaccinului contra bolii lui carre
EP0178928A3 (en) Vaccines
RU2002135684A (ru) Способ профилактики и лечения дерматомикозов, вакцина "полидерм" для его осуществления и способ никольского получения такой вакцины
RU2003100193A (ru) Способ изготовления инактивированной вакцины против синдрома снижения яйценоскости-76 птиц
UA67249A (en) Strain paramixovirus-3 bovis "m-87" for the preparation of vaccine and diagnostic antigen